Literature DB >> 16538520

Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms.

Fabio Rotondo1, Kalman Kovacs, Eva Horvath, C David Bell, Ricardo V Lloyd, Bernd W Scheithauer.   

Abstract

The aim of the present work was to investigate whether nestin, a member of the intermediate filament family, is immunohistochemically expressed in the non-tumoral human hypophysis and pituitary neoplasms. Twenty-three normal pituitaries and 125 pituitary neoplasms were included. The tissues were formalin-fixed and paraffin embedded. The neoplasms were identified on hematoxylin-eosin stained sections and were classified by immunohistochemistry as well as electron microscopy. For immunohistochemistry, the streptavidin-biotin-peroxidase complex method was applied using appropriate controls. Several corticotrophs in the autopsy obtained pituitaries showed cytoplasmic nestin immunopositivity. No nestin immunoreactivity was found in other cell types in non-tumorous adenohypophyses and in the cells of various pituitary adenomas. Nestin was, however, expressed in a small proportion of endothelial cells in both anterior and posterior lobes. Staining was also noted in several pituicytes, neurohypophysial nerve fibers, and Herring bodies. In contrast to CD-34 and Factor-8 immunostaining which demonstrated immunopositivity in practically all endothelial cells of every capillary, nestin expression was only focally seen suggesting that the functional status of the immunoreactive and non-staining endothelial cells was not the same. No statistically significant correlation was apparent between nestin immunoreactivity and patient age, gender, tumor size, mitotic index, Ki-67, labeling nuclear index, hormonal immunoprofile, and tumor type. In conclusion, nestin expression in adenomas cannot be viewed as a biologically relevant marker of cell proliferation and as a prognostic indicator. The patchy expression of nestin in endothelial cells remains unexplained and its significance requires further studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538520     DOI: 10.1007/s00401-006-0031-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Tumefactive postmenopausal gonadotroph cell hyperplasia.

Authors:  Mark Jentoft; Bernd W Scheithauer; Olga Moshkin; Eva Horvath; Phillip C Collins; Luis V Syro; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

2.  Adenohypophysitis in rat pituitary allografts.

Authors:  Fabio Rotondo; Andres Quintanar-Stephano; Sylvia L Asa; Matilde Lombardero; Istvan Berczi; Bernd W Scheithauer; Eva Horvath; Kalman Kovacs
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

3.  Pituitary immunoexpression of ghrelin in anorexia nervosa.

Authors:  Fabio Rotondo; Bernd W Scheithauer; Luis V Syro; Angelo Rotondo; Kalman Kovacs
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

4.  Enhanced nestin expression and small blood vessels in human pituitary adenomas.

Authors:  María Inés Perez-Millan; Silvia Inés Berner; Guillermina María Luque; Cristian De Bonis; Gustavo Sevlever; Damasia Becu-Villalobos; Carolina Cristina
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

5.  Pituitary adenoma with peliosis: a report of two cases.

Authors:  Safraz Mohammed; Luis V Syro; Bernd W Scheithauer; Alberto Abad; Humberto Uribe; Fabio Rotondo; Eva Horvath; Michael Cusimano; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

6.  Pineal gland expression of the transcription factor Egr-1 is restricted to a population of glia that are distinct from nestin-immunoreactive cells.

Authors:  Pui-Sin Man; David A Carter
Journal:  J Mol Histol       Date:  2007-08-02       Impact factor: 2.611

Review 7.  Angiogenesis in pituitary adenomas: human studies and new mutant mouse models.

Authors:  Carolina Cristina; Guillermina María Luque; Gianina Demarchi; Felicitas Lopez Vicchi; Lautaro Zubeldia-Brenner; Maria Ines Perez Millan; Sofia Perrone; Ana Maria Ornstein; Isabel M Lacau-Mengido; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Int J Endocrinol       Date:  2014-11-18       Impact factor: 3.257

8.  Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.

Authors:  Mingyu Zhang; Tao Song; Liang Yang; Ruokun Chen; Lei Wu; Zhuanyi Yang; Jiasheng Fang
Journal:  J Exp Clin Cancer Res       Date:  2008-12-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.